The FDA's positive feedback on Biogen Inc.'s Amevive application likely will be the first in a series of key events expected to drive the biotechnology industry this year, an analyst said.(BioWorld Today)
The FDA's positive feedback on Biogen Inc.'s Amevive application likely will be the first in a series of key events expected to drive the biotechnology industry this year, an analyst said.(BioWorld Today)
WASHINGTON - Members of a House subcommittee on Thursday were pointing their fingers in all sorts of directions, looking for someone to accept blame for the debacle surrounding ImClone Systems Inc.'s investigational cancer drug, Erbitux.(BioWorld Today)
WASHINGTON - Members of a House subcommittee on Thursday were pointing their fingers in all sorts of directions, looking for someone to accept blame for the debacle surrounding ImClone Systems Inc.'s investigational cancer drug, Erbitux.(BioWorld Today)
